Technology News and Research

RSS

Health Mason software to streamline health care claim payment process

With health care reform taking the national spotlight, the sole point of agreement by all parties is that some form of change is necessary. Many health care industry experts believe that now is the worst time for government-mandated change because innovation has already begun to occur organically from within the industry. One Franklin Tennessee-based software company is defining that innovation and garnering attention in the industry.

17 Nov 2009

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Arizona State University has been awarded nearly $3 million in federal stimulus funds from the National Institutes of Health. ASU professors Stuart Lindsay and Paul Westerhoff will lead a pair of two-year, innovative projects designed to tackle challenges in the fields of rapid DNA sequencing and the potential health risks of nanotechnology.

17 Nov 2009

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Targeted Genetics Corporation today announced its financial results for the third quarter ended September 30, 2009.

17 Nov 2009

Agilent Technologies acquires MassCode Tag technology from Eurofins MWG Operon

Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.

17 Nov 2009

Sterile Insect Technique can play a vital role in malaria elimination

The Sterile Insect Technique (SIT), the release of sexually sterile male insects to wipe out a pest population, is one suggested solution to the problem of malaria in Africa. A new supplement, published in BioMed Central's open access Malaria Journal, reviews the history of the technique, and features details about aspects of its application in the elimination of malaria.

16 Nov 2009

BrainStorm Cell's therapeutic approach has potential for treatment of neurodegenerative diseases

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company’s therapeutic approach for treating neurodegenerative diseases, particularly ALS and Parkinson’s disease, was found to have a positive effect in a mouse model of multiple sclerosis (MS).

16 Nov 2009

SynerMed and L.A. Care team up to launch e-consult program

SynerMed, Inc., the largest Medicaid managed service organization (MSO) in the country, in collaboration with L.A. Care Health Plan, the nation’s largest public health plan, announced today the launch of an e-consult pilot program.

16 Nov 2009

World Food Summit focuses on aiding agriculture in developing countries to fight hunger

Delegates at the World Summit on Food Security, which kicked off Monday, "rallied around a new strategy to fight global hunger and help poor countries feed themselves," the Associated Press reports.

16 Nov 2009

Carefx Fusionfx and Imprivata to provide integrated clinical access solution to Johns Hopkins Health System

Carefx Corporation, a leading provider of interoperable workflow solutions, and Imprivata®, Inc., the employee access management company, today announced that Johns Hopkins Health System, an internationally recognized group of healthcare institutions, has selected Carefx Fusionfx and Imprivata OneSign to deliver an integrated clinical access solution that streamlines access to workstations, applications and patient data. The complete, integrated system will launch in early 2010.

16 Nov 2009

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

16 Nov 2009

Talend bags orders from several global healthcare customers

Talend, the recognized market leader in open source data integration software, today announced several global healthcare customer wins including Children’s Hospital & Medical Center of Omaha, Hosta, The Clermont-Ferrand Hospital and The University for Health Sciences, Medical Informatics and Technology (UMIT). The traction gained in this space further validates Talend’s ability to provide scalable and flexible solutions at an affordable cost to healthcare organizations of all sizes, while satisfying the need for the real-time data the industry demands.

16 Nov 2009

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Seattle Genetics, Inc. today announced that it has initiated a phase I clinical trial of SGN-75 for metastatic renal cell carcinoma and relapsed and refractory non-Hodgkin lymphoma. SGN-75 is an antibody-drug conjugate (ADC) targeting CD70 that utilizes the company’s proprietary technology.

16 Nov 2009

Electronic health records not yet making impact, patients turn to web for advice

As the United States launches "an ambitious program, backed by $19 billion in government incentives, to accelerate the adoption of computerized patient records in doctors' offices and hospitals," a new study of 3,000 hospitals "has found little difference in the cost and quality of care," The New York Times reports.

16 Nov 2009

Eclipsys’ Sunrise Patient Flow solution activated successfully at Singapore General Hospital

Eclipsys Corporation®, The Outcomes Company®, today announced that Singapore General Hospital (SGH), Singapore's oldest and largest acute tertiary hospital and national referral center, has successfully activated Eclipsys’ Sunrise Patient Flow™ solution.

16 Nov 2009

Fate Therapeutics announces the completion of $30 million Series B financing

Fate Therapeutics, Inc. announced today that it has completed a $30 million Series B financing led by OVP Venture Partners. Joining OVP Venture Partners in the financing is a syndicate of corporate investors, including Astellas Venture Management, Genzyme Ventures and a third undisclosed corporate investor.

16 Nov 2009

First-quarter fiscal 2010 results announced by IsoRay

IsoRay Inc. a medical isotope company focusing on the treatment of prostate, lung, head and neck and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the first quarter of fiscal year 2010, ended September 30, 2009.

16 Nov 2009

Bright Now! Dental announces the opening of Castle Dental office in Kyle

Bright Now! Dental Inc., the nation’s leading provider of business support services to dentists, announces the grand opening of a new Castle Dental office in Kyle. Located at 5103 Kyle Center Drive in the Kyle Corners Shopping Center, the office provides families with a convenient, comfortable environment where they can receive the latest in comprehensive, full-serve quality dental care.

16 Nov 2009

Advanced Cell Technology to raise funds through private placements

Advanced Cell Technology, Inc., announced today that it has entered into definitive agreements on three private placements with institutional and other accredited investors under which the Company has received definitive commitments in excess of $15 million.

16 Nov 2009

Sunlight Saunas renamed as Sunlighten

After a thorough, long-term strategic brand-building process, Sunlighten(TM) has been chosen as the new name for health & wellness leader Sunlight Saunas(TM). Under the same ownership and with a renewed sense of corporate mission, Sunlighten has plans for a host of cutting-edge wellness products over the coming years, including advances in its line of long-celebrated infrared saunas.

16 Nov 2009

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.

16 Nov 2009

Technology News and Research

Health Mason software to streamline health care claim payment process

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Agilent Technologies acquires MassCode Tag technology from Eurofins MWG Operon

Sterile Insect Technique can play a vital role in malaria elimination

BrainStorm Cell's therapeutic approach has potential for treatment of neurodegenerative diseases

SynerMed and L.A. Care team up to launch e-consult program

World Food Summit focuses on aiding agriculture in developing countries to fight hunger

Carefx Fusionfx and Imprivata to provide integrated clinical access solution to Johns Hopkins Health System

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Talend bags orders from several global healthcare customers

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Electronic health records not yet making impact, patients turn to web for advice

Eclipsys’ Sunrise Patient Flow solution activated successfully at Singapore General Hospital

Fate Therapeutics announces the completion of $30 million Series B financing

First-quarter fiscal 2010 results announced by IsoRay

Bright Now! Dental announces the opening of Castle Dental office in Kyle

Advanced Cell Technology to raise funds through private placements

Sunlight Saunas renamed as Sunlighten

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News